Insider Transactions in Q1 2026 at Xeris Biopharma Holdings, Inc. (XERS)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 08
2026
|
Kevin Mc Culloch Officer |
SELL
Open market or private sale
|
Direct |
15,000
-0.88%
|
$120,000
$8.0 P/Share
|
|
Jan 05
2026
|
John Patrick Shannon Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
92,301
+1.09%
|
$184,602
$2.35 P/Share
|
|
Jan 05
2026
|
John Patrick Shannon Jr Director |
SELL
Open market or private sale
|
Direct |
24,907
-0.91%
|
$174,349
$7.08 P/Share
|
|
Jan 02
2026
|
Beth Hecht Officer |
SELL
Open market or private sale
|
Direct |
16,667
-1.26%
|
$116,669
$7.43 P/Share
|